{"product_id":"ara-290-peptide","title":"ARA-290 Peptide","description":"\u003cdiv class=\"flex max-w-full flex-col gap-4 grow\"\u003e\n\u003cdiv dir=\"auto\" class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+\u0026amp;]:mt-1\" tabindex=\"0\"\u003e\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden\"\u003e\n\u003cdiv class=\"markdown prose dark:prose-invert wrap-break-word w-full dark markdown-new-styling\"\u003e\n\u003ch2 class=\"PDq2pG_selectionAnchorContainer\"\u003eARA-290 Peptide\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003cp\u003eARA-290, also known as \u003cstrong\u003ecibinetide\u003c\/strong\u003e, is an investigational 11-amino-acid peptide derived from the helix-B region of erythropoietin (EPO). It was designed to study tissue-protective signaling through the proposed \u003cstrong\u003einnate repair receptor (IRR)\u003c\/strong\u003e while separating this activity from EPO's erythropoietic effects. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eResearch Areas\u003c\/h3\u003e\n\u003cp\u003eARA-290 has been investigated in research involving:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNeuroprotection and peripheral nerve biology\u003c\/li\u003e\n\u003cli\u003eNeuropathic and inflammatory processes\u003c\/li\u003e\n\u003cli\u003eTissue protection and repair signaling\u003c\/li\u003e\n\u003cli\u003eMetabolic and cellular stress pathways\u003c\/li\u003e\n\u003cli\u003eInflammation-related research\u003c\/li\u003e\n\u003cli\u003eEPO-derived receptor signaling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePreclinical studies have examined ARA-290 in models of nerve injury, ischemia-reperfusion injury and wound healing, while early clinical research has investigated conditions including diabetic neuropathy and sarcoidosis-associated neuropathy. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eScientific Profile\u003c\/h3\u003e\n\u003cp\u003eARA-290 is a short linear peptide with a molecular weight of approximately \u003cstrong\u003e1,257 Da\u003c\/strong\u003e. Its development was based on the observation that EPO's tissue-protective signaling can be pharmacologically separated from its classical red-blood-cell-producing activity. \u003cspan class=\"contents\"\u003e\u003cspan class=\"\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eResearch Status\u003c\/h3\u003e\n\u003cp\u003eARA-290 remains an \u003cstrong\u003einvestigational compound and is not an approved therapeutic product\u003c\/strong\u003e. Published research provides scientific interest in its receptor signaling and tissue-protection mechanisms, but this evidence should not be interpreted as establishing clinical efficacy or safety for general use.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan class=\"\"\u003eA quick note on product imagery:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan class=\"\"\u003eThe vial, packaging, or label you receive may vary slightly from what’s shown in the photos those are for reference only. Rest assured, the product itself and the specifications remain exactly as described above.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Corepeptides India","offers":[{"title":"Default Title","offer_id":54844520693973,"sku":null,"price":5999.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/5796\/2453\/files\/ChatGPTImageSep6_2026_10_03_58AM.png?v=1788669264","url":"https:\/\/corepeptides.in\/products\/ara-290-peptide","provider":"Corepeptides India","version":"1.0","type":"link"}